Applied Opt (AAOI) has had the highest return between 2023 and 2026 by a mid-cap US stock, returning 6,134.5%.
| ASSET | YEARS | % RETURN |
|---|
Applied Opt (AAOI) | 2023-2026 | 6,134.54% |
Dave (DAVE) | 2023-2026 | 4,074.14% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 2023-2026 | 3,880% |
Cipher Mining (CIFR) | 2023-2026 | 3,367.13% |
Rigetti Computing (RGTI) | 2023-2026 | 2,292% |
Innodata (INOD) | 2023-2026 | 2,136.36% |
Powell Industries (POWL) | 2023-2026 | 2,061.26% |
Argan (AGX) | 2023-2026 | 1,926.28% |
Definium Therapeutics (DFTX) | 2023-2026 | 1,846.7% |
Applied Digital (APLD) | 2023-2026 | 1,649.21% |
Dianthus Therapeutics (DNTH) | 2023-2026 | 1,419.65% |
D-Wave Quantum (QBTS) | 2023-2026 | 1,402% |
Almonty Industries Inc Common Shares (ALM) | 2023-2026 | 1,282.68% |
Aura Minerals Inc Common Shares (AUGO) | 2023-2026 | 1,188.08% |
Oscar Health (OSCR) | 2023-2026 | 1,187.2% |
AXT (AXTI) | 2023-2026 | 1,178.1% |
Liquidia Technologies (LQDA) | 2023-2026 | 1,139.09% |
Protagonist Therapeutics (PTGX) | 2023-2026 | 1,094.37% |
Pulse Biosciences (PLSE) | 2023-2026 | 954.33% |
Bitfarms (KEEL) | 2023-2026 | 952.75% |
Tutor Perini (TPC) | 2023-2026 | 909.74% |
Acm Research (ACMR) | 2023-2026 | 898.67% |
Immunome (IMNM) | 2023-2026 | 883.75% |
Trevi Therapeutics (TRVI) | 2023-2026 | 838.74% |
Praxis Precision Medicines (PRAX) | 2023-2026 | 831.35% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.